tetano
Editor, Senior Moderator
Sci Transl Med
. 2025 Dec 10;17(828):eadq0143.
doi: 10.1126/scitranslmed.adq0143. Epub 2025 Dec 10. Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination
Xu Cao[SUP] 1 2 [/SUP], Amit Manhas[SUP] 1 2 [/SUP], Yi-Ing Chen[SUP] 1 2 [/SUP], Arianne Caudal[SUP] 1 2 [/SUP], Gema Mondejar-Parreño[SUP] 1 2 [/SUP], Wenjuan Zhu[SUP] 1 2 [/SUP], Wenqiang Liu[SUP] 1 2 [/SUP], Xiaohui Kong[SUP] 1 2 [/SUP], Wenshu Zeng[SUP] 1 2 [/SUP], Lichao Liu[SUP] 1 2 [/SUP], Shane R Zhao[SUP] 1 2 [/SUP], James W S Jahng[SUP] 1 2 [/SUP], Paul J Utz[SUP] 3 4 [/SUP], Kari C Nadeau[SUP] 5 6 [/SUP], Masataka Nishiga[SUP] 1 2 [/SUP], Joseph C Wu[SUP] 1 2 7 8 [/SUP]
Affiliations
Messenger RNA (mRNA) vaccines against SARS-CoV-2 are highly effective and were instrumental in curbing the COVID-19 pandemic. However, rare cases of noninfective myocarditis, particularly in young males and typically after the second dose, have been observed. Here, we explore the mediators of this myocarditis to better understand and to enhance the safety of future mRNA vaccines. Through analysis of human plasma data and in vitro experiments with human macrophages and T cells, we identified increased C-X-C motif chemokine ligand 10 (CXCL10) and interferon-γ (IFN-γ) after exposure to BNT162b2 (Pfizer) or mRNA-1273 (Moderna). Neutralization of CXCL10 and IFN-γ during the second dose (21 days after the first dose) reduced vaccine-induced cardiac injury in mice. Neutralization also reduced cardiac stress markers such as the release of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and expression of inflammatory genes in human induced pluripotent stem cell (iPSC)-derived cardiac spheroids. When exposed to these cytokines in vitro, human iPSC-derived cardiomyocytes (iPSC-CMs) exhibited impaired contractility, arrhythmogenicity, and proinflammatory gene expression patterns. Genistein, a phytoestrogen implicated in reducing cardiovascular inflammation, mitigated these effects in iPSC-CMs. In mice exposed to these cytokines or receiving BNT162b2 vaccination, genistein treatment reduced cardiac injury markers and attenuated infiltration of neutrophils and macrophages into the heart. These findings implicate CXCL10-IFN-γ signaling as a contributor to myocardial injury in experimental models of mRNA vaccination and indicate that pharmacologic modulation, such as with genistein, may mitigate cytokine-driven injury.
. 2025 Dec 10;17(828):eadq0143.
doi: 10.1126/scitranslmed.adq0143. Epub 2025 Dec 10. Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination
Xu Cao[SUP] 1 2 [/SUP], Amit Manhas[SUP] 1 2 [/SUP], Yi-Ing Chen[SUP] 1 2 [/SUP], Arianne Caudal[SUP] 1 2 [/SUP], Gema Mondejar-Parreño[SUP] 1 2 [/SUP], Wenjuan Zhu[SUP] 1 2 [/SUP], Wenqiang Liu[SUP] 1 2 [/SUP], Xiaohui Kong[SUP] 1 2 [/SUP], Wenshu Zeng[SUP] 1 2 [/SUP], Lichao Liu[SUP] 1 2 [/SUP], Shane R Zhao[SUP] 1 2 [/SUP], James W S Jahng[SUP] 1 2 [/SUP], Paul J Utz[SUP] 3 4 [/SUP], Kari C Nadeau[SUP] 5 6 [/SUP], Masataka Nishiga[SUP] 1 2 [/SUP], Joseph C Wu[SUP] 1 2 7 8 [/SUP]
Affiliations
- PMID: 41370400
- DOI: 10.1126/scitranslmed.adq0143
Messenger RNA (mRNA) vaccines against SARS-CoV-2 are highly effective and were instrumental in curbing the COVID-19 pandemic. However, rare cases of noninfective myocarditis, particularly in young males and typically after the second dose, have been observed. Here, we explore the mediators of this myocarditis to better understand and to enhance the safety of future mRNA vaccines. Through analysis of human plasma data and in vitro experiments with human macrophages and T cells, we identified increased C-X-C motif chemokine ligand 10 (CXCL10) and interferon-γ (IFN-γ) after exposure to BNT162b2 (Pfizer) or mRNA-1273 (Moderna). Neutralization of CXCL10 and IFN-γ during the second dose (21 days after the first dose) reduced vaccine-induced cardiac injury in mice. Neutralization also reduced cardiac stress markers such as the release of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and expression of inflammatory genes in human induced pluripotent stem cell (iPSC)-derived cardiac spheroids. When exposed to these cytokines in vitro, human iPSC-derived cardiomyocytes (iPSC-CMs) exhibited impaired contractility, arrhythmogenicity, and proinflammatory gene expression patterns. Genistein, a phytoestrogen implicated in reducing cardiovascular inflammation, mitigated these effects in iPSC-CMs. In mice exposed to these cytokines or receiving BNT162b2 vaccination, genistein treatment reduced cardiac injury markers and attenuated infiltration of neutrophils and macrophages into the heart. These findings implicate CXCL10-IFN-γ signaling as a contributor to myocardial injury in experimental models of mRNA vaccination and indicate that pharmacologic modulation, such as with genistein, may mitigate cytokine-driven injury.